- Home
- QBTS vs FENC Comparison
QBTS vs FENC Comparison
Compare QBTS & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- FENC
- Stock Information
- Founded
- QBTS 1999
- FENC 1996
- Country
- QBTS Canada
- FENC United States
- Employees
- QBTS N/A
- FENC 29
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QBTS Technology
- FENC Health Care
- Exchange
- QBTS Nasdaq
- FENC Nasdaq
- Market Cap
- QBTS 194.5M
- FENC 156.9M
- IPO Year
- QBTS N/A
- FENC 2001
- Fundamental
- Price
- QBTS $5.77
- FENC $5.72
- Analyst Decision
- QBTS Strong Buy
- FENC Strong Buy
- Analyst Count
- QBTS 6
- FENC 2
- Target Price
- QBTS $6.38
- FENC $14.00
- AVG Volume (30 Days)
- QBTS 111.3M
- FENC 77.3K
- Earning Date
- QBTS 11-14-2024
- FENC 11-07-2024
- Dividend Yield
- QBTS N/A
- FENC N/A
- EPS Growth
- QBTS N/A
- FENC N/A
- EPS
- QBTS N/A
- FENC N/A
- Revenue
- QBTS $9,424,000.00
- FENC $49,348,000.00
- Revenue This Year
- QBTS $4.94
- FENC $170.43
- Revenue Next Year
- QBTS $63.93
- FENC $6.70
- P/E Ratio
- QBTS N/A
- FENC N/A
- Revenue Growth
- QBTS 14.27
- FENC 278.09
- 52 Week Low
- QBTS $0.68
- FENC $3.96
- 52 Week High
- QBTS $11.41
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- QBTS 49.31
- FENC 44.56
- Support Level
- QBTS $3.74
- FENC $5.61
- Resistance Level
- QBTS $6.35
- FENC $6.19
- Average True Range (ATR)
- QBTS 1.46
- FENC 0.26
- MACD
- QBTS -0.59
- FENC -0.09
- Stochastic Oscillator
- QBTS 32.59
- FENC 11.58
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is engaged in the development and delivery of quantum computing systems, software, and services, and is the commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modelling. D-Wave's annealing quantum computers are accessible through the Company's LeapTM cloud service.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.